Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Convalescent plasma Emergency use authorization Experimental Antiviral Jan/04/2022 40 10
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jul/12/2021 92 22
GC376 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021 12 0
Rutin Potential treatment - pre-clinical evidence Natural product Antiviral Apr/02/2021 9 0
Theaflavin 3,3'-digallate Potential treatment - theoretical effect Natural product Antiviral Mar/10/2021 3 0
Hypericin Potential treatment - theoretical effect Natural product Antiviral Mar/08/2021 8 0
Calpain inhibitor XII Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021 5 0
Calpain inhibitor II Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021 4 0
Azithromycin Potential treatment - clinical evidence Used to treat other disease Antiviral Feb/26/2021 19 10
Quercetin Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021 12 0